AbbVie (ABBV) PT Trimmed at Jefferies But Sees Excellent Entry Point

February 3, 2015 8:41 AM

Jefferies analyst Jeffrey Holford reiterated a Buy rating on Abbvie (NYSE: ABBV) following Q4 results but lowered his price target ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found